Cargando…

Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules

Background: CyberKnife SBRT is capable of producing dosimetry comparable to that created by HDR brachytherapy. Our original CyberKnife prostate SBRT schedule of 3,800 cGy/4 fractions (“high dose”) was based upon favorable published prostate HDR brachytherapy experience. Subsequently, our trial was m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuller, Donald Blake, Naitoh, John, Shirazi, Reza, Crabtree, Tami, Mardirossian, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331284/ https://www.ncbi.nlm.nih.gov/pubmed/32670876 http://dx.doi.org/10.3389/fonc.2020.00936

Ejemplares similares

Virtual HDR CyberKnife SBRT for Localized Prostatic Carcinoma: 5-Year Disease-Free Survival and Toxicity Observations
por: Fuller, Donald Blake, et al.
Publicado: (2014)

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
por: Fuller, Donald B., et al.
Publicado: (2022)

Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
por: Meier, Robert
Publicado: (2015)

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2014)

Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study
por: Katz, Alan Jay, et al.
Publicado: (2014)

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT
por: Alite, Fiori, et al.
Publicado: (2022)

Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer
por: Repka, Michael C., et al.
Publicado: (2022)

Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)

SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate Cancer
por: Azzam, Gregory, et al.
Publicado: (2015)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Translating the Immunobiology of SBRT to Novel Therapeutic Combinations for Advanced Prostate Cancer
por: Adorno Febles, Victor R., et al.
Publicado: (2020)

Cleaning the dose falloff in lung SBRT plan
por: Desai, Dharmin, et al.
Publicado: (2020)

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
por: Owen, Dawn, et al.
Publicado: (2015)

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)
por: Zhong, Jim, et al.
Publicado: (2022)

Dose prescription with spatial uncertainty for peripheral lung SBRT
por: Bedford, James L., et al.
Publicado: (2018)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Clinical usefulness of MLCs in robotic radiosurgery systems for prostate SBRT
por: Tomida, Masashi, et al.
Publicado: (2017)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

The delivered dose assessment in pancreas SBRT with the target position determined using an in-house position monitoring system
por: Arumugam, Sankar, et al.
Publicado: (2022)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)
por: Aghdam, Nima, et al.
Publicado: (2020)

Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)
por: Pepin, Abigail, et al.
Publicado: (2020)

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines
por: Bernetich, Matthew, et al.
Publicado: (2014)

Contour similarity and its implication on inverse prostate SBRT treatment planning
por: Yan, Chenyu, et al.
Publicado: (2022)

Reducing PTV margins for prostate SBRT with motion compensation and gating techniques
por: Goddard, Lee, et al.
Publicado: (2022)

Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)
por: Aghdam, Nima, et al.
Publicado: (2020)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis
por: Tang, Xiaofang, et al.
Publicado: (2020)

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
por: Hepel, Jaroslaw T., et al.
Publicado: (2012)

Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT)
por: Dupic, Guillaume, et al.
Publicado: (2020)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Selection Strategy of Jaw Tracking in VMAT Planning for Lung SBRT
por: Sun, Wuji, et al.
Publicado: (2022)

Clinical Evaluation of an Auto-Segmentation Tool for Spine SBRT Treatment
por: Chen, Yingxuan, et al.
Publicado: (2022)

Intra‐ and inter‐fractional liver and lung tumor motions treated with SBRT under active breathing control
por: Lu, Lan, et al.
Publicado: (2017)

A 2/1 Sunitinib Dosing Schedule Provides Superior Antitumor Effectiveness and Less Toxicity Than a 4/2 Schedule for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Deng, Huan, et al.
Publicado: (2020)

The use of a thin guide‐wire for urethral definition in prostate SBRT treatments with Cyberknife
por: Sevillano, David, et al.
Publicado: (2023)

The effect of integrating knowledge‐based planning with multicriteria optimization in treatment planning for prostate SBRT
por: Jayarathna, Sandun, et al.
Publicado: (2023)

Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
por: Hu, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_is725s8bui9r83e32ohohk4qi5